Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy
Clinical trial NCT03352934 · COMPLETED
Trial details
- NCT number
- NCT03352934
- Sponsor
- Johannes Gutenberg University Mainz
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-07
- Primary completion
- 2022-02-18
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.